Obesity is one of the biggest drivers of poor health, placing an immense strain on our health and welfare systems, and a drag on the UK economy. It is also increasingly a key driver of health inequalities, with current access to anti-obesity medications (AOM) largely based on ability to pay rather than need. The NHS recognises there’s a problem and plans to make Mounjaro available to 220,000 more people within three years, rising to 3.4 million over the next twelve years.
#soaring #price #Mounjaro #derail #NHSs #obesity #plan
